0
Signin
countryflagUS

18889881171

MSFT 425.025 -0.9035% AAPL 220.43 0.8648% NVDA 115.85 1.4004% GOOGL 172.44 -0.1101% GOOG 174.27 -0.0573% AMZN 182.99 1.1945% META 460.09 -0.2558% AVGO 152.64 0.859% TSLA 224.8499 4.102% TSM 161.61 1.1327% LLY 823.56 -4.2238% V 257.56 1.3338% JPM 209.535 0.453% UNH 562.83 0.5502% NVO 129.31 -1.7401% WMT 70.206 -0.5581% LVMUY 143.15 0.9022% XOM 116.85 1.5999% LVMHF 714.04 0.4982% MA 436.96 1.0429%

R1 RCM Inc

Healthcare US RCM

13.105USD
-0.045(0.34%)

Last update at 2024-07-25T16:53:00Z

Day Range

13.0413.18
LowHigh

52 Week Range

8.8718.70
LowHigh

Fundamentals

  • Previous Close 13.15
  • Market Cap5347.83M
  • Volume687190
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA538.30M
  • Revenue TTM2312.50M
  • Revenue Per Share TTM5.51
  • Gross Profit TTM 361.30M
  • Diluted EPS TTM-0.07

Analyst Recommendations

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -61.00000M 126.80M 118.40M 9.80M -56.70000M
Minority interest - - - - -
Net income -57.60000M 97.20M 117.10M 12.00M -45.30000M
Selling general administrative 174.80M 166.10M 102.40M 104.40M 97.90M
Selling and marketing expenses - - - - -
Gross profit 361.30M 311.80M 249.70M 198.30M 97.90M
Reconciled depreciation 172.00M 77.50M 68.70M 55.70M 38.80M
Ebit 3.00M 145.70M 80.00M 112.70M -30.40000M
Ebitda 175.00M 223.20M 148.70M 168.40M 8.40M
Depreciation and amortization 172.00M 77.50M 68.70M 55.70M 38.80M
Non operating income net other - - 55.70M -18.80000M -26.30000M
Operating income 3.00M 145.70M 80.00M 112.70M -30.40000M
Other operating expenses 1619.90M 1282.80M 1123.50M 1092.20M 898.90M
Interest expense 64.00M 18.90M 17.30M 102.90M 26.30M
Tax provision -3.40000M 29.60M 1.30M -2.20000M -11.40000M
Interest income - - - 29.10M 26.30M
Net interest income -64.00000M -18.90000M -17.30000M -29.10000M -26.30000M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense -3.40000M 29.60M 1.30M -2.20000M -11.40000M
Total revenue 1806.40M 1474.60M 1270.80M 1186.10M 868.50M
Total operating expenses 174.80M 120.00M 102.40M 104.40M 128.30M
Cost of revenue 1445.10M 1162.80M 1021.10M 987.80M 770.60M
Total other income expense net -64.00000M -18.90000M 38.40M -102.90000M -30.40000M
Discontinued operations - - - - -
Net income from continuing ops -57.60000M 97.20M 117.10M 12.00M -45.30000M
Net income applicable to common shares -57.60000M -495.10000M 47.40M -8.70000M -64.40000M
Preferred stock and other adjustments - 592.30M 22.40M 20.70M 19.10M
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 4960.20M 5139.80M 1449.30M 1189.00M 929.10M
Intangible assets 1310.70M 1514.50M 265.40M 171.10M 164.70M
Earning assets - - - - -
Other current assets 22.00M 110.30M 77.20M 59.40M 41.60M
Total liab 2208.80M 2419.30M 1102.60M 849.60M 911.00M
Total stockholder equity 2751.40M 2720.50M 346.70M 339.40M 18.10M
Deferred long term liab - 26.70M 23.40M 19.60M 20.80M
Other current liab 189.20M 179.60M 156.10M 111.60M 135.10M
Common stock 4.50M 4.40M 3.00M 1.40M 1.30M
Capital stock 4.50M 4.40M 3.00M 1.40M 1.30M
Retained earnings -136.70000M -121.90000M -64.30000M -161.50000M -277.80000M
Other liab - 242.50M 40.10M 52.60M 29.00M
Good will 2629.40M 2658.20M 554.70M 375.30M 253.20M
Other assets - 150.50M 120.90M 195.00M 99.70M
Cash 173.60M 110.10M 130.10M 173.80M 92.00M
Cash and equivalents - - - - -
Total current liabilities 346.20M 349.80M 254.20M 206.30M 232.50M
Current deferred revenue 42.20M 64.90M 49.40M 32.00M 48.10M
Net debt 1566.80M 1788.80M 709.20M 461.40M 357.50M
Short term debt 92.10M 71.90M 31.00M 44.50M 29.10M
Short long term debt 72.80M 53.90M 25.80M 34.20M 16.30M
Short long term debt total 1740.40M 1898.90M 839.30M 635.20M 449.50M
Other stockholder equity 2889.50M 2841.40M 413.30M 254.50M 70.00M
Property plant equipment - 245.30M 143.60M 151.50M 194.80M
Total current assets 633.30M 564.50M 364.70M 355.40M 216.70M
Long term investments - - - - -
Net tangible assets - -1459.00000M -473.40000M -207.00000M -399.80000M
Short term investments -29.50000M - - - -
Net receivables 379.50M 344.10M 157.40M 122.20M 83.10M
Long term debt 1570.50M 1732.60M 754.90M 519.70M 337.70M
Inventory 58.20M - 31.50M - -
Accounts payable 22.70M 33.40M 17.70M 18.20M 20.20M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -5.90000M -3.40000M -5.30000M -6.50000M -4.50000M
Additional paid in capital - - - - -
Common stock total equity - - 3.00M 1.40M 1.30M
Preferred stock total equity - - - - -
Retained earnings total equity - - -64.30000M -161.50000M -277.80000M
Treasury stock - - -215.20000M -139.20000M -73.60000M
Accumulated amortization - - - - -
Non currrent assets other 71.60M 146.90M 45.70M 62.00M 35.50M
Deferred long term asset charges - - - - -
Non current assets total 4326.90M 4575.30M 1084.60M 833.60M 712.40M
Capital lease obligations 97.10M 112.40M 66.90M 83.20M 95.50M
Long term debt total - - - - 338.30M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -949.50000M -340.40000M -117.00000M -61.00000M -462.80000M
Change to liabilities -16.00000M 28.80M -18.40000M 32.90M 38.70M
Total cashflows from investing activities -949.50000M -340.40000M -117.00000M -61.00000M -496.30000M
Net borrowings 1011.10M 217.80M 217.20M -7.20000M 357.30M
Total cash from financing activities 943.00M 31.40M 137.90M -25.30000M 377.40M
Change to operating activities -149.70000M 16.60M -61.90000M -23.50000M 59.80M
Net income -57.60000M 97.20M 117.10M 12.00M -45.30000M
Change in cash -20.00000M -44.70000M 82.30M 27.40M -101.30000M
Begin period cash flow 130.10M 174.80M 92.50M 65.10M 166.40M
End period cash flow 110.10M 130.10M 174.80M 92.50M 65.10M
Total cash from operating activities -9.90000M 264.80M 61.80M 113.90M 18.30M
Issuance of capital stock - - - 0.00000M 19.20M
Depreciation 172.00M 77.50M 68.70M 55.70M 38.80M
Other cashflows from investing activities -8.30000M -288.70000M -67.70000M 6.00M -462.80000M
Dividends paid - - 5.00M - 362.90M
Change to inventory - -44.00000M -1.20000M -24.90000M -7.20000M
Change to account receivables -51.80000M -33.20000M -56.50000M 11.50M -39.10000M
Sale purchase of stock -69.50000M -177.80000M -71.90000M -11.00000M -3.00000M
Other cashflows from financing activities 1068.00M 808.10M 254.00M 395.50M 725.40M
Change to netincome 113.70M 95.40M -28.10000M 32.40M 5.55M
Capital expenditures 93.50M 51.70M 49.30M 61.00M 33.50M
Change receivables - -33.20000M -56.50000M 11.50M -39.10000M
Cash flows other operating - -2.10000M -22.00000M -32.20000M 18.10M
Exchange rate changes - - - - -
Cash and cash equivalents changes - -44.20000M 82.70M 27.60M -100.60000M
Change in working capital -241.60000M -16.50000M -121.80000M -2.10000M 17.70M
Stock based compensation 67.10M 74.30M 24.10M 18.60M 18.40M
Other non cash items 57.00M 9.30M -25.10000M 34.80M 2.70M
Free cash flow -103.40000M 213.10M 12.50M 52.90M -15.20000M

Peer Comparison

Sector: Healthcare Industry: Health Information Services

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
RCM
R1 RCM Inc		 -0.045 0.34% 13.11 - 80.65 2.33 1.91 3.02 15.98
GEHC
GE HealthCare Technologies Inc.		 1.08 1.36% 80.77 22.91 20.12 2.01 5.52 2.39 13.30
VEEV
Veeva Systems Inc Class A		 5.39 2.93% 189.64 54.61 33.22 12.83 6.73 11.14 58.84
MTHRF
M3 Inc		 - -% 9.07 29.72 25.00 0.05 4.38 0.04 0.12
MTHRY
M3 Inc		 0.10 2.10% 4.86 31.84 26.25 0.05 4.60 0.04 0.12

Reports Covered

Stock Research & News

View All

Profile

R1 RCM Inc. provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers. The company also offers modular solutions, including functional partnership, an outsourcing solutions for improvements across targeted revenue cycle areas for hospital and physician group customers; revenue recovery, to fast-track payer and patient cash collections; revenue optimization, a solution to uncover missed or underreported revenue; clinical integrity, used to improve documentation and coding accuracy to maximize earned revenue for the services provided; and regulatory navigation, a compliance-first solutions for government reimbursement accuracy, pharmacy savings, and compliance. The company was incorporated in 2003 and is headquartered in Murray, Utah.

R1 RCM Inc

434 W. Ascension Way, Murray, UT, United States, 84123

Key Executives

Name Title Year Born
Mr. Joseph Gerard Flanagan CEO & Director 1971
Ms. Rachel Wilson Exec. VP, CFO & Treasurer 1973
Mr. John M. Sparby Exec. VP of Operations & Delivery and COO 1976
Mr. Gary S. Long Exec. VP & Chief Commercial Officer 1971
Mr. Lee Rivas Pres NA
Mr. Richard B. Evans Jr. Sr. VP, Corp. Controller & Chief Accounting Officer 1968
Mr. Jay Sreedharan Chief Technology & Digital Officer NA
Mr. Atif A. Rahim Sr. VP of Investor Relations & Bus. Devel. NA
Mr. Corey Perman Exec. VP of Compliance & Risk NA
Mr. Sean Radcliffe Exec. VP, Gen. Counsel & Corp. Sec. NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.